Johns Hopkins Medicine: 'Fast-Fail' AI Blood Test Could Steer Patients With Pancreatic Cancer Away From Ineffective Therapies
May 22, 2025
May 22, 2025
BALTIMORE, Maryland, May 22 -- Johns Hopkins Medicine issued the following news release:
* * *
'Fast-Fail' AI Blood Test Could Steer Patients with Pancreatic Cancer Away from Ineffective Therapies
An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood, developed by Johns Hopkins Kimmel Cancer Center investigators, could help clinicians more quickly identify and determine if pancrea . . .
* * *
'Fast-Fail' AI Blood Test Could Steer Patients with Pancreatic Cancer Away from Ineffective Therapies
An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood, developed by Johns Hopkins Kimmel Cancer Center investigators, could help clinicians more quickly identify and determine if pancrea . . .